Mega Genomics Limited (6667.HK)

HKD 7.71

(0.13%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021 2020 2019
Revenue 151.3 Million 145.72 Million 237.18 Million 203.22 Million 123.7 Million
Cost of Revenue 63 Million 64 Million 70.5 Million 56.97 Million 45.22 Million
Gross Profit 88.29 Million 81.72 Million 166.67 Million 146.24 Million 78.47 Million
Operating Expenses 69.77 Million 76.92 Million 45.31 Million 36.87 Million 19.27 Million
Selling, General and Administrative Expenses 61.23 Million 77.79 Million 25.62 Million 20.58 Million 6.33 Million
Research and Development Expenses - 19.43 Million 11.4 Million 4.44 Million 4.39 Million
Other Expenses 8.53 Million -869 Thousand 8.29 Million 11.84 Million 8.54 Million
Cost and Expenses 132.77 Million 140.92 Million 115.82 Million 93.84 Million 64.49 Million
Operating Income 18.52 Million 2.52 Million 106.19 Million 110.62 Million 64.32 Million
Interest Expense 1.12 Million 719 Thousand 6.91 Million 16.55 Million 19.58 Million
Income Tax Expense 6.14 Million -3.8 Million 16.86 Million 15.8 Million 8.6 Million
Earnings before Tax 36.17 Million -21.41 Million 95.88 Million 94.9 Million 38.29 Million
Net Income 30.03 Million -17.61 Million 79.01 Million 79.09 Million 29.69 Million
Earnings Per Share Basic 0.14 -0.09 0.62 0.33 0.12
Earnings Per Share Diluted 0.14 -0.09 0.62 0.33 0.12
Weighted Average Shares Outstanding 211.76 Million 206.29 Million 127.26 Million 239.23 Million 239.23 Million
Weighted Average Shares Outstanding (Diluted) 211.76 Million 206.29 Million 127.26 Million 239.23 Million 239.23 Million
Gross Margin 0.58 0.56 0.70 0.72 0.63
EBIT Margin 0.23 0.12 0.51 0.61 0.63
Profit Margin 0.20 -0.12 0.33 0.39 0.24
EBITDA 35.49 Million -5.42 Million 116.66 Million 125.49 Million 71.93 Million
Earnings Before Tax Margin 0.12 0.02 0.45 0.54 0.52

Income Statement Charts